Fairdeal Corporation

406.10
+4.25
(1.06%)
Market Cap
6,611.72 Cr
EPS
18.58
PE Ratio
23.88
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
658.85
52 Week Low
366.25
PB Ratio
2.86
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,711.85
#1 4,10,730.16
34.52
#1 49,887.20
12.06
#1 9,648
13.77
47.51
5,590.00
1,48,396.94
71.26
8,184.00
0.89
1,600
#1 64.53
39.79
1,444.00
1,16,619.60
23.38
26,520.70
14.17
4,155
47.38
43.02
3,195.35
1,08,145.16
57.83
10,785.70
11.59
1,656
13.54
53.52
2,435.05
1,00,464.93
49.65
10,615.60
19.57
1,942
-16.38
59.59
1,140.00
95,127.91
#1 17.90
28,905.40
12.36
5,578
1.69
45.68
1,988.85
90,799.15
31.14
20,141.50
#1 19.94
1,936
38.82
40.13
882.80
88,830.34
19.47
19,831.50
13.82
3,831
29.92
38.77
1,148.65
66,713.78
18.70
29,559.20
17.55
3,169
-10.04
47.43
29,899.85
63,535.09
48.26
6,097.20
10.80
1,201
16.01
52.15

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
11.51 %
Net Income Growth
57.43 %
Cash Flow Change
42.52 %
ROE
48.77 %
ROCE
43.91 %
EBITDA Margin (Avg.)
31.20 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
299
283
270
285
353
363
352
371
336
390
375
328
471
428
355
351
514
458
428
442
566
514
483
482
667
549
483
Expenses
218
216
200
229
265
272
237
304
205
266
267
264
332
326
294
322
417
378
360
386
414
410
374
406
492
444
418
EBITDA
81
66
71
56
88
91
116
67
132
125
109
65
139
102
61
29
97
80
68
56
151
104
109
77
175
105
66
Operating Profit %
25 %
21 %
22 %
15 %
23 %
21 %
26 %
9 %
34 %
28 %
22 %
16 %
26 %
18 %
14 %
6 %
16 %
15 %
12 %
11 %
23 %
16 %
18 %
12 %
23 %
14 %
10 %
Depreciation
9
9
8
8
9
10
9
9
9
10
9
10
10
10
9
9
9
10
10
10
10
10
10
10
11
14
13
Interest
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
72
57
63
48
78
80
106
57
121
114
99
54
128
91
51
19
87
69
57
45
141
93
98
65
163
90
51
Tax
23
16
17
13
22
26
32
1
30
26
24
7
31
19
15
9
16
17
16
15
31
23
18
19
44
18
14
Net Profit
49
40
46
35
56
54
74
56
92
88
75
47
98
72
36
10
71
52
41
31
110
70
79
46
119
72
37
EPS in ₹
2.80
2.31
2.62
2.00
3.22
3.14
4.31
3.22
5.36
5.15
4.45
2.77
5.80
4.28
2.11
0.62
4.23
3.10
2.45
1.85
6.62
4.22
4.86
2.84
7.31
4.43
2.28

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,149
1,266
1,468
1,505
1,640
1,813
1,956
2,270
2,343
2,468
Fixed Assets
393
675
678
674
682
674
689
705
699
680
Current Assets
502
523
708
722
740
927
934
1,000
1,027
1,067
Capital Work in Progress
29
20
6
13
12
24
19
105
198
262
Investments
273
325
491
471
585
665
790
886
806
843
Other Assets
454
246
293
348
360
451
458
575
640
684
Total Liabilities
1,149
1,266
1,468
1,505
1,640
1,813
1,956
2,270
2,343
2,468
Current Liabilities
188
163
179
212
179
246
204
272
312
311
Non Current Liabilities
24
20
18
18
16
19
19
42
50
60
Total Equity
936
1,083
1,270
1,276
1,445
1,547
1,734
1,956
1,981
2,097
Reserve & Surplus
919
1,065
1,252
1,259
1,428
1,530
1,717
1,940
1,966
2,081
Share Capital
18
18
18
18
18
17
17
17
17
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-9
4
11
1
-8
10
1
7
-14
2
Investing Activities
-89
-73
-144
21
-121
-98
-77
-145
11
-17
Operating Activities
128
174
155
150
112
250
207
162
155
221
Financing Activities
-48
-97
0
-169
-0
-142
-129
-10
-180
-202

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
69.35 %
69.35 %
69.35 %
69.36 %
69.36 %
69.50 %
69.50 %
69.50 %
69.50 %
69.50 %
69.66 %
69.66 %
69.66 %
69.66 %
69.66 %
69.66 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.65 %
2.51 %
2.62 %
2.67 %
DIIs
3.98 %
4.28 %
4.57 %
5.37 %
5.81 %
6.00 %
6.72 %
7.76 %
8.27 %
8.95 %
8.00 %
7.61 %
6.94 %
6.73 %
6.03 %
6.08 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.15 %
16.82 %
16.79 %
16.61 %
16.32 %
16.35 %
16.05 %
15.42 %
14.93 %
15.59 %
15.94 %
16.12 %
16.54 %
16.71 %
16.70 %
16.57 %
Others
10.52 %
9.55 %
9.29 %
8.67 %
8.51 %
8.15 %
7.73 %
7.32 %
7.31 %
5.96 %
6.40 %
6.61 %
4.22 %
4.39 %
5.00 %
5.02 %
No of Share Holders
0
40,327
49,335
49,889
53,582
86,503
65,318
63,172
57,012
56,717
56,928
55,341
52,377
50,634
55,400
55,228

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.25 0.00 0.00 0.8 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.9 0.00 0.00 0.28 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Closure of Trading Window6 days ago
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 19, 2025
Integrated Filing (Financial)Feb 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Unaudited Financial Results For Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter And Nine Months Ended 31St December2024Feb 12, 2025
Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.Feb 07, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015Jan 31, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Intimation Of Change In Name Of CompanyS Registrar And Share Transfer Agent (RTA)Jan 02, 2025
Intimation Regarding Approval Received From US FDA For ANDA- Cefixime 400 Mg TabletsDec 18, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 13, 2024
Announcement Under Regulation 30 (LODR) - Intimation Of Company''s New Correspondence AddressDec 12, 2024
Receipt Of Establishment Inspection Report (EIR) From US FDA With No Observations (Zero 483 S), As Closure Of Inspection Conducted At Company''s Manufacturing Facility Located At Baddi, Himachal Pradesh.Nov 13, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2024
Corporate Action-Fixation Of Record Date For 1St Interim Dividend For FY 24-25.Nov 06, 2024
Corporate Action-Board approves DividendNov 06, 2024
Unaudited ( Standalone And Consolidated) Financial Results For Quarter And Half Year Ended On September 30,2024.Nov 06, 2024
Board Meeting Outcome for Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter And Half Year Ended 3Oth September 2024Nov 06, 2024
Board Meeting Intimation for Board Meeting Scheduled To Be Held On November 06,2024.Oct 28, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Closure of Trading WindowSep 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 24, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Sep 11, 2024
Update W.R.T. Composition Of Board Committees Of FDC Limited.Sep 06, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 06, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 06, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Business Responsibility and Sustainability Reporting (BRSR)Sep 03, 2024
Notice Of The 84Th Annual General Meeting (AGM) Of FDC LimitedSep 03, 2024
Reg. 34 (1) Annual Report.Sep 03, 2024
Intimation Of Book Closure And Cut-Off Date In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirement) Regulation 2015Sep 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2024
US-FDA Inspection At Company''s Manufacturing Facility Located At Baddi, Himachal PradeshAug 23, 2024
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 08, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 08, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2024
Quarterly Financial Results For The Period Ended June 30, 2024Aug 07, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2024Aug 07, 2024
Board Meeting Intimation for Board Meeting Intimation For Un-Audited Standalone &Consolidated Financial Results Of The Company For The QuarterEnded June 30, 2024.Jul 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJul 24, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 22, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 22, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 22, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 12, 2024
Closure of Trading WindowJun 25, 2024

Technical Indicators

RSI(14)
Neutral
46.32
ATR(14)
Less Volatile
15.13
STOCH(9,6)
Neutral
43.46
STOCH RSI(14)
Neutral
57.35
MACD(12,26)
Bullish
1.96
ADX(14)
Strong Trend
36.00
UO(9)
Bearish
47.03
ROC(12)
Uptrend And Accelerating
1.13
WillR(14)
Neutral
-47.87